KOA SHOJI HOLDINGS CO.,LTD. Logo

KOA SHOJI HOLDINGS CO.,LTD.

Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.

9273 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
横浜市港北区日吉七丁目13−15
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

KOA SHOJI HOLDINGS CO., LTD. is a pharmaceutical holding group operating a dual business model that combines a trading company and a manufacturer. The group specializes in supporting the pharmaceutical industry "from upstream" by importing and distributing high-quality, safe, and reliable Active Pharmaceutical Ingredients (APIs) for the Japanese market. In addition to its core trading activities, the company also manufactures and sells generic drugs. Its integrated operations, which include contract manufacturing and packaging services, aim to provide a stable supply chain for its customers and address the healthcare needs of an aging society.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for KOA SHOJI HOLDINGS CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-20 03:20
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2025-02-13 05:00
Interim Report
半期報告書-第11期(2024/07/01-2025/06/30)
Japanese 191.9 KB
2025-02-13 05:00
Regulatory News Service
確認書
Japanese 8.1 KB
2024-09-30 08:27
Regulatory News Service
臨時報告書
Japanese 24.6 KB
2024-09-30 08:26
Regulatory News Service
内部統制報告書-第10期(2023/07/01-2024/06/30)
Japanese 23.4 KB
2024-09-30 08:26
Regulatory News Service
確認書
Japanese 8.1 KB
2024-09-30 08:25
Annual Report
有価証券報告書-第10期(2023/07/01-2024/06/30)
Japanese 1.5 MB
2024-06-26 08:25
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2024-06-05 09:30
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 86.2 KB
2024-06-05 09:30
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 171.1 KB
2024-05-27 08:00
Prospectus
有価証券届出書(参照方式)
Japanese 101.1 KB
2024-05-27 08:00
Prospectus
有価証券届出書(参照方式)
Japanese 250.3 KB
2024-05-13 08:30
Regulatory News Service
確認書
Japanese 8.1 KB
2024-05-13 08:30
Quarterly Report
四半期報告書-第10期第3四半期(2024/01/01-2024/03/31)
Japanese 156.7 KB
2024-02-14 07:30
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all KOA SHOJI HOLDINGS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for KOA SHOJI HOLDINGS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG
Galderma Group AG Logo
A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.
Switzerland GALD
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GENFIT Logo
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
France GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark GMAB
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom GSK

Talk to a Data Expert

Have a question? We'll get back to you promptly.